US FDA expands use of Merck's cancer drug for adrenal gland tumors

(Reuters) -The U.S. Food and Drug Administration said connected Wednesday it has approved the expanded usage of Merck's crab cause to dainty 2 types adrenal gland tumors.

The drug, Welireg, became the archetypal FDA-approved oral attraction for the 2 tumors — pheochromocytoma and paraganglioma.

The regulator's support was based connected a survey successful which Welireg showed an nonsubjective effect complaint of 20.6%. ORR is the percent of radical who person a partial effect oregon implicit effect to the attraction wrong a definite play of time.

(Reporting by Puyaan Singh successful Bengaluru; Editing by Shilpi Majumdar)